Qurient’s Mocaciclib Opens New Combination Frontiers for Hard-to-Treat Breast Cancer
Qurient announced on June 29 that it presented key clinical data highlighting the mechanistic advantages of its CDK7-inhibiting oncology candidate,...
Search results for "HER2"
From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’
The standard of care in cancer treatment is undergoing a rapid paradigm shift. For decades, the default oncological approach relied on aggressive...
Datroway Approved: New Targeted Therapy Offers Hope for Metastatic Breast Cancer
A new therapeutic horizon has arrived for patients battling metastatic breast cancer that has progressed despite...
Can We Break Through Chemotherapy Resistance? A New Target for Triple-Negative Breast Cancer Appears
Among breast cancers, ‘triple-negative breast cancer ’ is particularly challenging to treat.
Abl Bio Confirms Positive Effects of Cancer Drug 'ABL111' in Phase 1b Clinical Trial
Abl Bio announced on the 7th that it has confirmed positive anti-cancer efficacy in the dose expansion cohort of the...
Breast Cancer Treatment, Does Adding ‘This’ Increase Survival Rates?
A domestic research team has announced findings that could improve the prognosis of breast cancer patients.